Time-averaged hemoglobin values, not hemoglobin cycling, have an impact on outcomes in pediatric dialysis patients
PEDIATRIC NEPHROLOGY, cilt.33, sa.11, ss.2143-2150, 2018 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 33 Sayı: 11
- Basım Tarihi: 2018
- Doi Numarası: 10.1007/s00467-018-4013-4
- Dergi Adı: PEDIATRIC NEPHROLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.2143-2150
- Anahtar Kelimeler: Dialysis, Hemoglobin cycling, Left ventricular hypertrophy, Pediatric patients, LEFT-VENTRICULAR HYPERTROPHY, CHRONIC KIDNEY-DISEASE, HEMODIALYSIS-PATIENTS, LEVEL VARIABILITY, BLOOD-PRESSURE, ANEMIA, ERYTHROPOIETIN, MORTALITY, ASSOCIATIONS, CHILDREN
- Çukurova Üniversitesi Adresli: Evet
Özet
During erythropoietin-stimulating agent (ESA) treatment, hemoglobin (Hb) levels usually fluctuate; this phenomenon is known as "Hb cycling (HC)." In this study, we aimed to evaluate the predictors of HC and its impact on left ventricular hypertrophy (LVH) as a patient-important outcome parameter in pediatric dialysis patients.